Bank Maspion Indonesia Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp490 (market cap 8.78T, 20.7K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 14.59M 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 18.7× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (14.59M versus 20.7K). Which is the better fit depends on your goals.
| BMAS | PRDL | |
|---|---|---|
Market Cap | 8.78T | 470.58B |
Volume | 20.7K | 14.59M |
Lot | 207 | 145.93K |
Turnover | 10.23M | 3.84B |
Average Price | 494.42 | 263.18 |
Value | 10.23M | 3.84B |
Indicative Equilibrium Price | — | 272 |
Indicative Equilibrium Volume | — | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →